Akums Drugs and Pharmaceutical (AKUMS) — Financial Flexibility Index
Akums Drugs and Pharmaceutical (AKUMS) has a Financial Flexibility Index of 0.64x as of September 2025. Free cash flow of Rs12.64 Billion (operating CF Rs11.52 Billion minus capex Rs1.12 Billion) represents 1% of total liabilities (Rs19.91 Billion). Check how aggressively does Akums Drugs and Pharmaceutical reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Akums Drugs and Pharmaceutical Financial Flexibility Index (2022–2026)
Historical Financial Flexibility Index trend for Akums Drugs and Pharmaceutical across 5 annual periods. For the full cash flow conversion analysis, see AKUMS operating cash flow.
Annual Financial Flexibility Index for Akums Drugs and Pharmaceutical (2022–2026)
Year-by-year free cash flow to debt coverage for Akums Drugs and Pharmaceutical. Explore AKUMS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.68x | Rs14.41 Billion | Rs12.11 Billion | Rs21.16 Billion | ▼ -3.0% |
| 2025 | 0.70x | Rs7.38 Billion | Rs4.65 Billion | Rs10.50 Billion | ▲ +142.6% |
| 2024 | 0.29x | Rs8.10 Billion | Rs4.98 Billion | Rs27.96 Billion | ▲ +45.7% |
| 2023 | 0.20x | Rs5.05 Billion | Rs1.77 Billion | Rs25.43 Billion | ▲ +67.8% |
| 2022 | 0.12x | Rs2.89 Billion | Rs318.54 Million | Rs24.44 Billion | — |